Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
3Customers
3Debt Items
0Related Chains
Source-Backed Evidence Depth
vTv Therapeutics Inc. (VTVT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
8Total relationships
2Distinct source URLs
7High confidence
0.870Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
vTv Therapeutics Inc. Suppliers
Ticker
Name
Confidence
Evidence
G42-INVESTMENTS
G42-INVESTMENTS
90%
A premium was paid on the Class A common stock by G42 Investments of $ 18.7 million, net of a note receivable discount of $ 0.6 million, which was deferred and recorded as a contract liability.
vTv Therapeutics Inc. Customers
Ticker
Name
Confidence
Evidence
G42-HEALTHCARE
G42-HEALTHCARE
92%
The Company will receive royalties in the single digits from G42 Healthcare on the net sales of cadisegliatin for a period of at least ten years after the first commercial sale of cadisegliatin in th…
NEWSOARA-BIOPHARMA-CO-LTD
NEWSOARA-BIOPHARMA-CO-LTD
92%
Under the new Second Amendment, Newsoara's rights in the Company's PDE4 inhibitor, HPP737, will expand to include all countries of the world upon Newsoara's payment of the upfront fee of $20 million.
M-F-TTP-HOLDINGS-TWO-LLC
M-F-TTP-HOLDINGS-TWO-LLC
62%
tion capabilities; • the costs of acquiring, licensing or investing in businesses, products, drug candidates and technologies; • our ability to maintain, expand and defend the scope of our intellectu…
vTv Therapeutics Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
VTVT-DEBT-13465
Warrants outstanding: 167000
90%
xbrl warrant detail from xbrl 2023-12-31.
VTVT-DEBT
Debt stack $2.4M
90%
Market cache reports total debt of $2.4M.
VTVT-DEBT-13466
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2018-12-31.
vTv Therapeutics Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for vTv Therapeutics Inc..
vTv Therapeutics Inc. Ownership
Holder
Name
Confidence
Evidence
VTVT-OWNER-SAMSARA-BIOCAPITAL-LLC
SAMSARA BIOCAPITAL, LLC
90%
13F overlay lists SAMSARA BIOCAPITAL, LLC as top holder; 35 tracked holders.
vTv Therapeutics Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
